they seem to be neutral on the market not offering much potential upside currently.discount to NTA will remain until they show us 20% pa returns - nothing happening as yet
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025